p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer
Emily Powell(The University of Texas at Austin), Helen Piwnica‐Worms(Centre for Cancer Biology)
Cited by 50
Related Papers
The Chk1 Protein Kinase and the Cdc25C Regulatory Pathways Are Targets of the Anticancer Agent UCN-01
|Journal of Biological Chemistry|2000|541
Kinetics of regulated protein–protein interactions revealed with firefly luciferase complementation imaging in cells and living animals
|Proceedings of the National Academy of Sciences|2004|443
Contribution of p53 to Metastasis
|Cancer Discovery|2014|368
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
|Science Translational Medicine|2019|316